Publisher： Bentham Science Publishers
E-ISSN： 2212-4055|11|3|222-226
ISSN： 1871-5281
Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.11, Iss.3, 2012-06, pp. : 222-226
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Advances in the Treatment of Chronic Granulomatous Disease by Gene Therapy
Current Gene Therapy, Vol. 7, Iss. 3, 2007-06 ,pp. :
Access to resources
Recommend
Adalimumab: Chronic granulomatous disease: case report
Reactions Weekly, Vol. 1, Iss. 1159, 2007-01 ,pp. :
Current treatment options for chronic granulomatous disease
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. :
Chronic Graft-Versus-Host Disease
Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. :